Cargando…
Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours
Cardiotoxicity is a well-recognised side effect of cancer-related therapies with a great impact on outcomes and quality of life in the cancer survivor population. The pathogenesis of chemotherapy-induced cardiotoxicity in patients with gastrointestinal cancers involves various molecular mechanisms,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400748/ https://www.ncbi.nlm.nih.gov/pubmed/34441012 http://dx.doi.org/10.3390/medicina57080806 |
_version_ | 1783745388466929664 |
---|---|
author | Radulescu, Liliana Maria Radulescu, Dan Ciuleanu, Tudor-Eliade Crisan, Dana Buzdugan, Elena Romitan, Dragos-Mihai Buzoianu, Anca Dana |
author_facet | Radulescu, Liliana Maria Radulescu, Dan Ciuleanu, Tudor-Eliade Crisan, Dana Buzdugan, Elena Romitan, Dragos-Mihai Buzoianu, Anca Dana |
author_sort | Radulescu, Liliana Maria |
collection | PubMed |
description | Cardiotoxicity is a well-recognised side effect of cancer-related therapies with a great impact on outcomes and quality of life in the cancer survivor population. The pathogenesis of chemotherapy-induced cardiotoxicity in patients with gastrointestinal cancers involves various molecular mechanisms, and the combined use of various chemotherapies augments the risk of each drug used alone. In terms of cardiotoxicity diagnosis, novel biomarkers, such as troponins, brain natriuretic peptide (BNP), myeloperoxidases and miRNAs have been recently assessed. Echocardiography is a noninvasive imaging method of choice for the primary assessment of chemotherapy-treated patients to generally evaluate the cardiovascular impact of these drugs. Novel echocardiography techniques, like three-dimensional and stress echocardiography, will improve diagnosis efficacy. Cardiac magnetic resonance (CMR) can evaluate cardiac morphology, function and wall structure. Corroborated data have shown the importance of CMR in the early evaluation of patients with gastrointestinal cancers, treated with anticancer drugs, but further studies are required to improve risk stratification in these patients. In this article, we review some important aspects concerning the cardiotoxicity of antineoplastic drugs used in gastrointestinal cancers. We also discuss the mechanism of cardiotoxicity, the role of biomarkers and the imaging methods used in its detection. |
format | Online Article Text |
id | pubmed-8400748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84007482021-08-29 Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours Radulescu, Liliana Maria Radulescu, Dan Ciuleanu, Tudor-Eliade Crisan, Dana Buzdugan, Elena Romitan, Dragos-Mihai Buzoianu, Anca Dana Medicina (Kaunas) Review Cardiotoxicity is a well-recognised side effect of cancer-related therapies with a great impact on outcomes and quality of life in the cancer survivor population. The pathogenesis of chemotherapy-induced cardiotoxicity in patients with gastrointestinal cancers involves various molecular mechanisms, and the combined use of various chemotherapies augments the risk of each drug used alone. In terms of cardiotoxicity diagnosis, novel biomarkers, such as troponins, brain natriuretic peptide (BNP), myeloperoxidases and miRNAs have been recently assessed. Echocardiography is a noninvasive imaging method of choice for the primary assessment of chemotherapy-treated patients to generally evaluate the cardiovascular impact of these drugs. Novel echocardiography techniques, like three-dimensional and stress echocardiography, will improve diagnosis efficacy. Cardiac magnetic resonance (CMR) can evaluate cardiac morphology, function and wall structure. Corroborated data have shown the importance of CMR in the early evaluation of patients with gastrointestinal cancers, treated with anticancer drugs, but further studies are required to improve risk stratification in these patients. In this article, we review some important aspects concerning the cardiotoxicity of antineoplastic drugs used in gastrointestinal cancers. We also discuss the mechanism of cardiotoxicity, the role of biomarkers and the imaging methods used in its detection. MDPI 2021-08-06 /pmc/articles/PMC8400748/ /pubmed/34441012 http://dx.doi.org/10.3390/medicina57080806 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Radulescu, Liliana Maria Radulescu, Dan Ciuleanu, Tudor-Eliade Crisan, Dana Buzdugan, Elena Romitan, Dragos-Mihai Buzoianu, Anca Dana Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours |
title | Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours |
title_full | Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours |
title_fullStr | Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours |
title_full_unstemmed | Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours |
title_short | Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours |
title_sort | cardiotoxicity associated with chemotherapy used in gastrointestinal tumours |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400748/ https://www.ncbi.nlm.nih.gov/pubmed/34441012 http://dx.doi.org/10.3390/medicina57080806 |
work_keys_str_mv | AT radulesculilianamaria cardiotoxicityassociatedwithchemotherapyusedingastrointestinaltumours AT radulescudan cardiotoxicityassociatedwithchemotherapyusedingastrointestinaltumours AT ciuleanutudoreliade cardiotoxicityassociatedwithchemotherapyusedingastrointestinaltumours AT crisandana cardiotoxicityassociatedwithchemotherapyusedingastrointestinaltumours AT buzduganelena cardiotoxicityassociatedwithchemotherapyusedingastrointestinaltumours AT romitandragosmihai cardiotoxicityassociatedwithchemotherapyusedingastrointestinaltumours AT buzoianuancadana cardiotoxicityassociatedwithchemotherapyusedingastrointestinaltumours |